EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.Legal Entity

Associated business (6)

• EISAI ONCOLOGY MEDICAL
  oncologyPharmaceuticalsManufacturing

  At Eisai Oncology Global Medical Affairs, we are driven to pursue innovative solutions to help address cancers with unmet needs. human health care (hhc) is our goal. At Eisai, everything we do is guided by a simple principle: patients and their families come first, and we have a responsibility to listen to and learn from them. We call this human health care or hhc.\n\nDuring these unprecedented times, our hhc mission is as important as ever. At Eisai, we recognize the mental and physical challenges cancer patients and their loved ones face each day. Therefore, it is our responsibility to share our research and development programs through online channels, so that health care professionals, researchers, and scientists have up-to-date information and access.\n\nCommunity Guidelines: https://www.eisaioncologymedical.com/community-guidelines

  View full profile
• EISAI CO., LTD.

  Japan
  PharmaceuticalsManufacturing

  Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.\n\nIn addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.

  View full profile
• EISAI INACTIVE PAGE
  HealthcarePharmaceuticalsInnovationMedicineUnmetMedicalNeedsQualityProducts+2 more

  Eisai Inc. is a global healthcare company that discovers, develops, and markets innovative drugs and therapies to improve the lives of patients worldwide. Our mission is to create and deliver high-quality products that meet unmet medical needs and make a meaningful difference in people's lives.

  View full profile
• EISAI (SINGAPORE) PTE. LTD.

  Singapore
  neurology and oncologyPharmaceuticalsManufacturing

  A leading global research and development-based pharmaceutical company headquartered in Japan, focused on neurology and oncology therapeutic areas, aiming to be a 'Medico Societal Innovator' by creating medicines and providing solutions to fulfill patients' unmet needs.

  View full profile
• EISAI (M) SDN BHD

  Malaysia
  FMCG (Manufacturing)Manufacturing

  View full profile
• EISAI US

  United States of America
  epilepsyoncologyinsomniametastatic breast cancerrenal cell carcinomahepatocellular carcinoma+7 more

  At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.\n\nEisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.\n\nComments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

  View full profile